(c) 2024 PillSync.com

fesoterodine fumarate 8 mg

1 INDICATIONS AND USAGE Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1 Adult Overactive Bladder Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information is approved for Pfizer Inc.’s TOVIAZ ® (fesoterodine fumarate) extended-release tablets. However, due to Pfizer Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.

amneal pharmaceuticals llc


1 year ago OVAL BLUE A70 fesoterodine fumarate 8 mg

OVAL BLUE A70

16 HOW SUPPLIED/STORAGE AND HANDLING

FESOTERODINE FUMARATE extended-release tablets, 4 mg, are supplied as light blue colored, oval shaped, and film-coated; debossed with “A 69” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 65162-369-03 Bottles of 90: NDC 65162-369-09

FESOTERODINE FUMARATE extended-release tablets, 8 mg , are supplied as blue colored, oval shaped, and film-coated; debossed with “A 70” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 65162-370-03 Bottles of 90: NDC 65162-370-09 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from moisture.


More pills like OVAL A70

Related Pills

fesoterodine fumarate 4 mg

amneal pharmaceuticals llc

ezetimibe 10 MG Simvastatin 10 MG Oral Tablet

Amneal Pharmaceuticals NY LLC












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site